Bustamante, Regine Fher S.
HRN: 21-22-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
04/13/2024
04/17/2024
PO
2.5ml As Single Dose, Then 1.2ml OD X 4 Days
5 Days
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes